Biomarkers for Inflammatory Breast Cancer: Diagnostic and Therapeutic Utility
Barbora Dobiasova, Michal Mego 2nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovak RepublicCorrespondence: Michal Mego 2 nd Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute, Klenova 1, Bratisl...
Saved in:
Main Authors: | Dobiasova B, Mego M |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/02dcb47d941a4a6a9f0c1b0d187f4a58 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
by: Kexin Xu, et al.
Published: (2021) -
Current advances in biomarkers for targeted therapy in triple-negative breast cancer
by: Fleisher B, et al.
Published: (2016) -
Preoperative Systemic Inflammatory Biomarkers Are Independent Predictors of Disease Recurrence in ER+ HER2- Early Breast Cancer
by: Marta Truffi, et al.
Published: (2021) -
Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
by: Jesse Lopes da Silva, et al.
Published: (2021) -
An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors
by: Koleck TA, et al.
Published: (2017)